Mini E - Search Results

1

Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.

Morganti M, Coronnello M, Caciagli B, Biondi C, Quattrone A, Capaccioli S, Mazzei T, Mini E. Morganti M, et al. Among authors: mini e. Anticancer Drugs. 2000 Apr;11(4):285-94. doi: 10.1097/00001813-200004000-00010. Anticancer Drugs. 2000. PMID: 10898545

2

Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.

Capaccioli S, Di Pasquale G, Mini E, Mazzei T, Quattrone A. Capaccioli S, et al. Among authors: mini e. Biochem Biophys Res Commun. 1993 Dec 15;197(2):818-25. doi: 10.1006/bbrc.1993.2552. Biochem Biophys Res Commun. 1993. PMID: 8267621

3

Evaluation of methotrexate sensitivity in human leukemia cell lines by an adenosine triphosphate bioluminescence assay.

Pinzani P, Carotti S, Gerli A, Pazzagli M, Mazzei T, Mini E. Pinzani P, et al. Among authors: mini e. Anticancer Drugs. 1997 Sep;8(8):767-77. doi: 10.1097/00001813-199709000-00006. Anticancer Drugs. 1997. PMID: 9396621

4

Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.

Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Tonelli F, Cortesini C, Capaccioli S, Ficari F, Quattrone A, Rossi S, Mazzei T. Mini E, et al. Oncol Res. 1999;11(9):437-45. Oncol Res. 1999. PMID: 10821538

5

Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation.

Mini E, Stanyon R, Coronnello M, Gerli A, Mazzei T, Periti P. Mini E, et al. Tumori. 1991 Apr 30;77(2):95-9. doi: 10.1177/030089169107700201. Tumori. 1991. PMID: 2048234

6

Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents.

Coronnello M, Ciciani G, Mini E, Guerrini G, Caciagli B, Selleri S, Costanzo A, Mazzei T. Coronnello M, et al. Among authors: mini e. Anticancer Drugs. 2005 Jul;16(6):645-51. doi: 10.1097/00001813-200507000-00009. Anticancer Drugs. 2005. PMID: 15930893

7

Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.

Pizzorno G, Mini E, Coronnello M, McGuire JJ, Moroson BA, Cashmore AR, Dreyer RN, Lin JT, Mazzei T, Periti P, et al. Pizzorno G, et al. Among authors: mini e. Cancer Res. 1988 Apr 15;48(8):2149-55. Cancer Res. 1988. PMID: 2450647

8

Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate.

Mini E, Pizzorno G, Coronnello M, McGuire JJ, Mazzei T, Periti P, Bertino JR. Mini E, et al. Pharmacol Res Commun. 1988 May;20(5):445-6. doi: 10.1016/s0031-6989(88)80035-3. Pharmacol Res Commun. 1988. PMID: 2458604 No abstract available.

9

Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.

Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S. Quattrone A, et al. Among authors: mini e. Oncol Res. 1994;6(7):311-20. Oncol Res. 1994. PMID: 7865906

10

Intracellular enhancement of intact antisense oligonucleotide steady-state levels by cationic lipids.

Quattrone A, Papucci L, Schiavone N, Mini E, Capaccioli S. Quattrone A, et al. Among authors: mini e. Anticancer Drug Des. 1994 Dec;9(6):549-53. Anticancer Drug Des. 1994. PMID: 7880379 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters